发明名称 HYDROXAMIC ACID COMPOUNDS
摘要 A compound of the following formula: (see fig. I) and its pharmaceutically acceptable salt thereof, wherein R1 and R~ are independently hydrogen, C1-4 alkyl, C3-7 cycloalkyl, C2-4 alke nyl,C1-4 alkoxy-C1-4 alkyl, C1-4 alkylthio-C1-4 alkyl, p henyl, phenyl-C1-4alkyl, halo-substituted C1-4 alkyl, C3-7 cycloalkyl-C1-3 alkyl or hydroxy-C1-4alkyl ; or R1 and R~ are taken together with the nitrogen to which they are attached and form optionally substituted, saturated or unsaturated 3-, 4-, 5-, 6- or 7- member ed heterocyclic containing one to two heteroatoms, provided that the heterocycl ic is not pyrrolidinyl; R3 is hydrogen, C1-4 alkyl or a hydroxy protecting group; Ar is optionally substituted phenyl or phenyl-C1-3 alkyl; and X is optionally substituted phenyl, naphthyl, biphenyl, indanyl, benzofuran yl, benzothiophenyl, 1-tetralone-6-yl, C1-4 alkylenedioxy, pyridyl, furyl or thienyl. These compounds and pharmaceutical compositions containing them are useful as analgesic, antiinflammatory, diuretic, antitussive, anesthetic or neuroprotective agents, or an agent for treatment of stroke or functional bo wel disease such as abdominal pain, for the treatment of a mammalian subject, especially a human subject.
申请公布号 CA2196845(A1) 申请公布日期 1997.08.08
申请号 CA19972196845 申请日期 1997.02.05
申请人 PFIZER INC. 发明人 ITO, FUMITAKA
分类号 C07D295/12;A61K31/00;A61K31/165;A61K31/395;A61K31/40;A61K31/445;A61K31/4453;A61K31/55;A61P7/00;A61P7/10;A61P11/00;A61P11/14;A61P25/00;A61P25/04;A61P29/00;C07C259/06;C07D205/04;C07D207/20;C07D211/70;C07D295/125;(IPC1-7):C07C239/16;C07D307/56;C07C323/47;A61K31/33;C07D333/28;A61K31/16;C07D295/15;C07D405/12;C07D309/12 主分类号 C07D295/12
代理机构 代理人
主权项
地址